1124 related articles for article (PubMed ID: 32786189)
1. The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
Howlader N; Forjaz G; Mooradian MJ; Meza R; Kong CY; Cronin KA; Mariotto AB; Lowy DR; Feuer EJ
N Engl J Med; 2020 Aug; 383(7):640-649. PubMed ID: 32786189
[TBL] [Abstract][Full Text] [Related]
2. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
3. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
4. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
5. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.
Ganti AK; Klein AB; Cotarla I; Seal B; Chou E
JAMA Oncol; 2021 Dec; 7(12):1824-1832. PubMed ID: 34673888
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence and mortality of lung cancer in Switzerland: Possible explanations and open questions.
Frisone D; Sandoval J; Friedlaender A; Olivier T; Addeo A
Cancer Epidemiol; 2022 Oct; 80():102232. PubMed ID: 35905519
[TBL] [Abstract][Full Text] [Related]
7. Trends in incidence and associated risk factors of suicide mortality in patients with non-small cell lung cancer.
Zhou H; Xian W; Zhang Y; Chen G; Zhao S; Chen X; Zhang Z; Shen J; Hong S; Huang Y; Zhang L
Cancer Med; 2018 Aug; 7(8):4146-4155. PubMed ID: 29971970
[TBL] [Abstract][Full Text] [Related]
8. Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Tian J; Song X; Wu B; Liu L
J Cancer Res Clin Oncol; 2018 Jan; 144(1):145-155. PubMed ID: 28980067
[TBL] [Abstract][Full Text] [Related]
9. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.
Govindan R; Page N; Morgensztern D; Read W; Tierney R; Vlahiotis A; Spitznagel EL; Piccirillo J
J Clin Oncol; 2006 Oct; 24(28):4539-44. PubMed ID: 17008692
[TBL] [Abstract][Full Text] [Related]
10. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
Goncalves PH; Peterson SL; Vigneau FD; Shore RD; Quarshie WO; Islam K; Schwartz AG; Wozniak AJ; Gadgeel SM
Cancer; 2016 Jun; 122(12):1921-7. PubMed ID: 27062154
[TBL] [Abstract][Full Text] [Related]
11. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females.
Travis WD; Lubin J; Ries L; Devesa S
Cancer; 1996 Jun; 77(12):2464-70. PubMed ID: 8640694
[TBL] [Abstract][Full Text] [Related]
12. The Change Trend of Cause of Death in Patients With Stage I Non-Small Cell Lung Cancer After Surgery in US: A Long-Term Follow-Up Study Based on SEER Database.
Peng WD; Xie J; Zhang X; Li C
Cancer Control; 2020; 27(1):1073274820954461. PubMed ID: 33070629
[TBL] [Abstract][Full Text] [Related]
13. Association of Stage Shift and Population Mortality Among Patients With Non-Small Cell Lung Cancer.
Flores R; Patel P; Alpert N; Pyenson B; Taioli E
JAMA Netw Open; 2021 Dec; 4(12):e2137508. PubMed ID: 34919136
[TBL] [Abstract][Full Text] [Related]
14. Residence in Rural Areas of the United States and Lung Cancer Mortality. Disease Incidence, Treatment Disparities, and Stage-Specific Survival.
Atkins GT; Kim T; Munson J
Ann Am Thorac Soc; 2017 Mar; 14(3):403-411. PubMed ID: 28118039
[TBL] [Abstract][Full Text] [Related]
15. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns and outcomes change in early-stage non-small cell lung cancer in octogenarians and older: a SEER database analysis.
Bei Y; Chen X; Raturi VP; Liu K; Ye S; Xu Q; Lu M
Aging Clin Exp Res; 2021 Jan; 33(1):147-156. PubMed ID: 32246386
[TBL] [Abstract][Full Text] [Related]
17. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
18. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464
[TBL] [Abstract][Full Text] [Related]
19. Temporal trends in the incidence and relative survival of non-small cell lung cancer in Canada: A population-based study.
Akhtar-Danesh N; Finley C
Lung Cancer; 2015 Oct; 90(1):8-14. PubMed ID: 26215032
[TBL] [Abstract][Full Text] [Related]
20. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
